These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2859204)

  • 1. Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine.
    Cohen AF; Hamilton MJ; Liao SH; Findlay JW; Peck AW
    Eur J Clin Pharmacol; 1985; 28(2):197-204. PubMed ID: 2859204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness.
    Peck AW; Fowle AS; Bye C
    Eur J Clin Pharmacol; 1975 Aug; 8(6):455-63. PubMed ID: 1233248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study.
    Gibson JR; Harvey SG; Barth JH; Moss MY; Burke CA
    Dermatologica; 1984; 169(4):179-83. PubMed ID: 6149965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.
    Neittaanmäki H; Fräki JE; Gibson JR
    Dermatologica; 1988; 177(2):98-103. PubMed ID: 2901993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man.
    Hamilton M; Bush M; Bye C; Peck AW
    Br J Clin Pharmacol; 1982 Mar; 13(3):441-4. PubMed ID: 6120718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE; Adams J; Posner J
    J Int Med Res; 1989; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of triprolidine and dipipanone in the cold induced pain test, and the central nervous system of healthy volunteers.
    Telekes A; Holland RL; Withington DA; Peck AW
    Br J Clin Pharmacol; 1987 Jul; 24(1):43-50. PubMed ID: 3620284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects.
    Cohen AF; Hamilton M; Philipson R; Peck AW
    Clin Pharmacol Ther; 1985 Oct; 38(4):381-6. PubMed ID: 3840066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two antihistamine drugs on actual driving performance.
    Betts T; Markman D; Debenham S; Mortiboy D; McKevitt T
    Br Med J (Clin Res Ed); 1984 Jan; 288(6413):281-2. PubMed ID: 6140978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.
    Brookhuis KA; De Vries G; De Waard D
    Br J Clin Pharmacol; 1993 Jul; 36(1):67-70. PubMed ID: 8104017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the H1-receptor antagonist triprolidine: pharmacokinetics and antihistaminic effects.
    Simons KJ; Singh M; Gillespie CA; Simons FE
    J Allergy Clin Immunol; 1986 Feb; 77(2):326-30. PubMed ID: 3944383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers.
    Rolan PE; Phillips S; Adams J; Posner J
    Eur J Clin Pharmacol; 1990; 39(3):311-3. PubMed ID: 1979541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch ; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance.
    Cohen AF; Hamilton MJ; Peck AW
    Eur J Clin Pharmacol; 1987; 32(3):279-88. PubMed ID: 2885203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the antihistamine activity of acrivastine and its onset in human skin.
    Manna VK; Marks P; Gibson JR
    J Int Med Res; 1992 Apr; 20(2):106-11. PubMed ID: 1355745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo controlled dose response study of noberastine on histamine induced weal and flare.
    Kamali F; Emanuel M; Rawlins MD
    Eur J Clin Pharmacol; 1991; 40(1):83-5. PubMed ID: 1676366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acrivastine and terfenadine on skin reactivity to histamine.
    Leynadier F; Murrieta M; Dry J; Colin JN; Gillotin C; Steru D
    Ann Allergy; 1994 Jun; 72(6):520-4. PubMed ID: 7911286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two antihistamine drugs on actual driving performance.
    Cohen AF; Posner J
    Br Med J (Clin Res Ed); 1984 Mar; 288(6421):935. PubMed ID: 6142749
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of astemizole/pseudoephedrine and triprolidine/pseudoephedrine on CNS activity and psychomotor function.
    Stanley N; Alford CA; Rombaut NE; Hindmarch I
    Int Clin Psychopharmacol; 1996 Mar; 11(1):31-6. PubMed ID: 8732311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.